🔎 Trials Near Me

Home › Urothelial (Transitional Cell) Carcinoma › District of Columbia

Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa District of Columbia

7 pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa mga site sa District of Columbia.

Mga Lungsod sa District of Columbia

Opisyal na teksto ng pag-aaral (English)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • MedStar Georgetown University Hospital, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  • Sibley Memorial Hospital Pharmacy Department, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • MedStar Washington Hospital Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

  • Research Site, Washington D.C.
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07815665

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  • Medstar Washington Hospital Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06774131

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • Medstar Washington Hospital Center, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04879329

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.